Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells
Open Access
- 13 July 2017
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 8 (7) , e2924
Abstract
The acquisition of epithelial–mesenchymal transition (EMT) and/or existence of a sub-population of cancer stem-like cells (CSC) are associated with malignant behavior and chemoresistance. To identify which factor could promote EMT and CSC formation and uncover the mechanistic role of such factor is important for novel and targeted therapies. In the present study, we found that the long intergenic non-coding RNA linc-DYNC2H1-4 was upregulated in pancreatic cancer cell line BxPC-3-Gem with acquired gemcitabine resistance. Knockdown of linc-DYNC2H1-4 decreased the invasive behavior of BxPC-3-Gem cells while ectopic expression of linc-DYNC2H1-4 promoted the acquisition of EMT and stemness of the parental sensitive cells. Linc-DYNC2H1-4 upregulated ZEB1, the EMT key player, which led to upregulation and downregulation of its targets vimentin and E-cadherin respectively, as well as enhanced the expressions of CSC makers Lin28, Nanog, Sox2 and Oct4. Linc-DYNC2H1-4 is mainly located in the cytosol. Mechanically, it could sponge miR-145 that targets ZEB1, Lin28, Nanog, Sox2, Oct4 to restore these EMT and CSC-associated genes expressions. We proved that MMP3, the nearby gene of linc-DYNC2H1-4 in the sense strand, was also a target of miR-145. Downregulation of MMP3 by miR-145 was reverted by linc-DYNC2H1-4, indicating that competing with miR-145 is one of the mechanisms for linc-DYNC2H1-4 to regulate MMP3. In summary, our results explore the important role of linc-DYNC2H1-4 in the acquisition of EMT and CSC, and the impact it has on gemcitabine resistance in pancreatic cancer cells.Keywords
This publication has 46 references indexed in Scilit:
- Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinomaWorld Journal of Surgical Oncology, 2013
- Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients’ quality of lifeWorld Journal of Surgical Oncology, 2013
- Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinomaWorld Journal of Surgical Oncology, 2013
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclassesGenes & Development, 2011
- Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNAScience, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cellsCell Death & Differentiation, 2009
- Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysisJournal of Hematology & Oncology, 2009
- p53 represses c-Myc through induction of the tumor suppressor miR-145Proceedings of the National Academy of Sciences, 2009
- Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancerJournal of Hematology & Oncology, 2009